Cargando…
A review of potential mechanisms and uses of SGLT2 inhibitors in ischemia-reperfusion phenomena
Recently added to the therapeutic arsenal against chronic heart failure as a first intention drug, the antidiabetic drug-class sodium-glucose cotransporter-2 inhibitors (SGLT2i) showed efficacy in decreasing overall mortality, hospitalization, and sudden death in patients of this very population, in...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521445/ https://www.ncbi.nlm.nih.gov/pubmed/36188147 http://dx.doi.org/10.4239/wjd.v13.i9.683 |